Delivery Order FA500015D0013-G002

<p>This is a federal contract award from the U.S. Department of Health and Human Services (HHS) to Fleming and Company Pharmaceuticals, a pharmaceutical company. The contract is for the delivery of DRUGS AND BIOLOGICALS, with a ceiling value of $11,928,795.00. It is a firm fixed-price delivery order contract with a period of performance ending on March 16, 2010. The contract does not have a set-aside designation.</p>

This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,571.55 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of substance use disorders. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...

This federal contract award was made by the Office of the Director to Life Technologies Corporation, doing business as Thermo Fisher Scientific, a prominent manufacturer of scientific instruments, reagents, and consumables. The $10,430.20 Firm Fixed Price contract is for the delivery of &quot;DRUGS AND BIOLOGICALS&quot; and was awarded on July 21, 2014, with an ultimate completion date of April 30, 2015. This contract was not set aside. Life Technologies Corporation, the prime contractor, is a...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Renflex IS 100 mg vials, a biosimilar medication used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis. This firm fixed-price delivery order, valued at $5,400.46, was awarded on December 15, 2025, with an ultimate completion date of December 16, 2025, and was competitively awarded without a set-aside designation. The work will be performed...

This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $5,615.88, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...

This federal contract award to Life Technologies Corporation, doing business as Thermo Fisher Scientific, is for the delivery of DRUGS AND BIOLOGICALS. The $4,800 Firm Fixed Price contract is a BPA Call, issued without a set-aside designation. The contract is funded by the Office of the Director, a civilian agency. The award is associated with two significant federal contract Indefinite Delivery Vehicles (IDVs) held by Life Technologies Corporation: a $3.5 million multi-award Blanket Purchase...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,330.52 to AmerisourceBergen Drug Corp for Adalimumab-aaty(cf) 80mg/0.8mls, a biosimilar immunosuppressant medication used to treat autoimmune conditions. This firm fixed-price, competitively awarded contract is scheduled for completion by December 22, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of VIVITROL 380 mg vial-diluents. This competitive award, utilizing firm fixed-price pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The delivery order carries an ultimate completion date of...

This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN94H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $2,002.34 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of April 24, 2025 and is not...

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply VIVITROL 380 MG VIAL-DILUENTS. The $2,269.15 order, which has no set-aside designation, is to be completed by December 26, 2023. AmerisourceBergen Drug Corp, through its Corporate Office division, is an experienced provider of pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense....